Table 3.

Poisson regression evaluating the influence of any antifungal prophylaxis (N = 722) or antimold prophylaxis (N = 62)

Infection	N	Any antifungal prophylaxis				Any antimold prophylaxis
		IRR (95% CI)	P	Adjusted IRR (95% CI)	Adjusted P*	IRR	P	Adjusted IRR (95% CI)	Adjusted P*
Any sterile-site bacterial infection	612	0.96 (0.84-1.09)	.514	0.94 (0.82-1.07)	.371	0.88 (0.71-1.09)	.244	0.94 (0.75-1.18)	.584
Gram-positive sterile-site bacterial infection	512	0.85 (0.73-0.99)	.041	0.82 (0.70-0.97)	.021	0.70 (0.52-0.95)	.023	0.70 (0.50-0.98)	.036
Gram-negative sterile-site bacterial infection	78	1.02 (0.59-1.79)	.932	1.21 (0.64-2.31)	.560	1.36 (0.63-2.95)	.433	1.46 (0.63-3.39)	.379
C difficile infection	123	1.28 (0.83-1.98)	.263	1.24 (0.80-1.94)	.339	0.38 (0.14-1.03)	.056	0.40 (0.15-1.09)	.074
Sterile-site fungal infection	49	1.06 (0.52-2.18)	.865	1.62 (0.69-3.83)	.271	1.59 (0.63-4.01)	.321	1.62 (0.58-4.56)	.361

^*Analysis adjusted for age, race, and weight group.